BullFrog AI Holdings, Inc. (BFRGW) stock
BFRGWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRG
$0.12+0.02 (+18.00%)
Close on Oct 30, 2026Market cap $9.04MP/E –Yield –
BullFrog AI r&d expenses
Research and development expenses are spending on new products and technology.
BullFrog AI's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.52M, down 31.5% year over year. For fiscal 2025 it was $1.80M, down 19.0% from the year before. The highest annual figure on record is $2.22M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.80M | -19.0% |
| FY2024 | Dec 31, 2024 | $2.22M | +55.2% |
| FY2023 | Dec 31, 2023 | $1.43M | +135.1% |
| FY2022 | Dec 31, 2022 | $609.27K | +2337.1% |
| FY2021 | Dec 31, 2021 | $25.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $339.46K | -29.3% |
| Q1 FY2026 | Mar 31, 2026 | $434.82K | -24.5% |
| Q4 FY2025 | Dec 31, 2025 | $397.19K | -32.8% |
| Q3 FY2025 | Sep 30, 2025 | $345.99K | -38.9% |
| Q2 FY2025 | Jun 30, 2025 | $480.30K | -6.5% |
| Q1 FY2025 | Mar 31, 2025 | $576.26K | +4.4% |
| Q4 FY2024 | Dec 31, 2024 | $590.86K | +44.5% |
| Q3 FY2024 | Sep 30, 2024 | $566.58K | +49.1% |
| Q2 FY2024 | Jun 30, 2024 | $513.70K | +87.7% |
| Q1 FY2024 | Mar 31, 2024 | $552.13K | +49.3% |
| Q4 FY2023 | Dec 31, 2023 | $409.00K | +154.2% |
| Q3 FY2023 | Sep 30, 2023 | $380.02K | +864.0% |
| Q2 FY2023 | Jun 30, 2023 | $273.67K | +195.3% |
| Q1 FY2023 | Mar 31, 2023 | $369.93K | +17.0% |
| Q4 FY2022 | Dec 31, 2022 | $160.90K | – |
| Q3 FY2022 | Sep 30, 2022 | $39.42K | – |
| Q2 FY2022 | Jun 30, 2022 | $92.67K | – |
| Q1 FY2022 | Mar 31, 2022 | $316.28K | – |